These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 759526)

  • 1. Biochemical quantitation of the chemotactic factor inactivator activity in human serum.
    Fantone J; Senior RM; Kreutzer DL; Jones M; Ward PA
    J Lab Clin Med; 1979 Jan; 93(1):17-24. PubMed ID: 759526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the protease activity in the chemotactic factor inactivator.
    Ward PA; Ozols J
    J Clin Invest; 1976 Jul; 58(1):123-9. PubMed ID: 6489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release.
    Ogawa H; Kunkel SL; Fantone JC; Ward PA
    Am J Pathol; 1981 Nov; 105(2):149-55. PubMed ID: 7294162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors.
    Kreutzer DL; O'Flaherty JT; Orr W; Showell HJ; Ward PA; Becker EL
    Immunopharmacology; 1978 Dec; 1(1):39-47. PubMed ID: 45788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
    Johnson KJ; Anderson TP; Ward PA
    J Clin Invest; 1977 May; 59(5):951-8. PubMed ID: 140184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
    Perez HD; Horn JK; Ong R; Goldstein IM
    J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosis.
    Spilberg I; Gallacher A; Mandell B
    J Lab Clin Med; 1977 Apr; 89(4):817-22. PubMed ID: 191547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.